Indacaterol + Glycopyrronium is a fixed-dose combination medication for inhalation consisting of the following two active ingredients: Indacaterol maleate – an ultra-long-acting beta-adrenoceptor agonist (ultra-LABA) and Glycopyrronium bromide (glycopyrrolate) – a muscarinic anticholinergic. Indacaterol + Glycopyrronium is used as a maintenance bronchodilator treatment to relieve symptoms in adult patients with …
Read More »Glimepiride 1 mg Tablet | Formulation & Manufacturing Process
Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. It is regarded as a second-line option compared to metformin, due to metformin’s well-established safety and efficacy. Use of glimepiride is recommended in conjunction with lifestyle modifications such as diet and exercise. …
Read More »Flupentixol 0.5 mg + Melitracen 10 mg Tablet | Formulation & Manufacturing Process
This consists of two well-known and well-proven compounds: flupentixol neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and melitracen bipolar thymoleptic with activating properties in low doses. In combination, the compounds render a preparation with antidepressant, anxiolytic, and activating properties. A maximal serum concentration …
Read More »Fexofenadine Hydrochloride 30 mg/5 ml Suspension | Formulation & Manufacturing Process
Fexofenadine is an antihistamine pharmaceutical drug used in the treatment of allergy symptoms, such as hay fever and urticaria. Therapeutically, fexofenadine is a selective peripheral H1 blocker. It is classified as a second-generation antihistamine because it is less able to pass the blood–brain barrier and cause sedation, compared to first-generation …
Read More »Etoricoxib 120 mg Tablet | Formulation & Manufacturing Process
Etoricoxib is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data. Etoricoxib is indicated for “the …
Read More »Etoricoxib 90 mg Tablet | Formulation & Manufacturing Process
Etoricoxib is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data. Etoricoxib is indicated for “the …
Read More »Etoricoxib 60 mg Tablet | Formulation & Manufacturing Process
Etoricoxib is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data. Etoricoxib is indicated for “the …
Read More »Empagliflozin 25 mg Tablet | Formulation & Manufacturing Process
Empagliflozin is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. It is not recommended for type 1 diabetes. It is taken by mouth. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar loss in urine. Empagliflozin was approved …
Read More »Empagliflozin 10 mg Tablet | Formulation & Manufacturing Process
Empagliflozin is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. It is not recommended for type 1 diabetes. It is taken by mouth. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar loss in urine. Empagliflozin was approved …
Read More »Empagliflozin 5 mg + Metformin Hydrochloride 500 mg Tablet | Formulation & Manufacturing Process
Empagliflozin is an inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2). SGLT2 is the predominant transporter, responsible for the re-absorption of glucose from the kidney back into circulation. By inhibiting SGLT2, Empagliflozin reduces renal re-absorption of filtered glucose and lowers the renal threshold for glucose thereby increasing urinary glucose excretion. Metformin hydrochloride …
Read More »Doxophylline 400 mg Tablet | Formulation & Manufacturing Process
Doxophylline (also known as Doxofylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. In animal and human studies, it has shown similar efficacy to theophylline but with significantly fewer side effects. In February …
Read More »Doxophylline 200 mg Tablet | Formulation & Manufacturing Process
Doxophylline (also known as Doxofylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. In animal and human studies, it has shown similar efficacy to theophylline but with significantly fewer side effects. In February …
Read More »Doxophylline 100 mg/5 ml Syrup | Formulation & Manufacturing Process
Doxophylline (also known as Doxofylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. In animal and human studies, it has shown similar efficacy to theophylline but with significantly fewer side effects. In February …
Read More »Diclofenac Sodium 100 mg Capsule | Formulation & Manufacturing Process
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. It is taken by mouth or rectally in a suppository, used by injection, or applied to the skin. Improvements in pain last for as much as eight hours. It is also available in …
Read More »Clopidogrel 75 mg + Aspirin 75 mg Tablet | Formulation & Manufacturing Process
Clopidogrel is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent (dual antiplatelet therapy). It is taken by mouth. Its effect starts …
Read More »Clopidogrel 75 mg Tablet | Formulation & Manufacturing Process
Clopidogrel is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent (dual antiplatelet therapy). It is taken by mouth. Its effect starts …
Read More »Clobetasol Propionate 0.05% + Neomycin Sulphate 0.5% + Nystatin 100000 IU/gm Cream | Formulation & Manufacturing Process
It is the combination of Clobetasol Propionate, Neomycin Sulphate, and Nystatin. Clobetasol Propionate is a very potent corticosteroid. It is prescribed to treat severe inflammatory skin disorders such as eczema and psoriasis that have not responded to weaker corticosteroids. Neomycin Sulphate is an antibiotic of the aminoglycoside type and is …
Read More »Cholecalciferol (Vitamin D3) 40000 IU Capsule | Formulation & Manufacturing Process
Cholecalciferol, also known as vitamin D3, is a type of vitamin D that is made by the skin when exposed to sunlight; it is found in some foods and can be taken as a dietary supplement. Cholecalciferol is made in the skin following UVB light exposure. It is converted in …
Read More »Cholecalciferol (Vitamin D3) 20000 IU Capsule | Formulation & Manufacturing Process
Cholecalciferol, also known as vitamin D3, is a type of vitamin D that is made by the skin when exposed to sunlight; it is found in some foods and can be taken as a dietary supplement. Cholecalciferol is made in the skin following UVB light exposure. It is converted in …
Read More »Cefuroxime 500 mg + Clavulanic Acid 125 mg Tablet | Formulation & Manufacturing Process
Cefuroxime is a bactericidal second-generation cephalosporin antibiotic that is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase-producing strains. Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process.Clavulanic acid is a naturally derived beta-lactamase inhibitor produced by Streptomyces clavuligerus. It has a …
Read More »